Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer

Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer

Abstract Members of the human epidermal growth factor receptor (HER) family play a significant role in bladder cancer progression and may underlie the development of chemotherapy resistance. Dacomitinib is an irreversible tyrosine kinase inhibitor with structural specificity for the catalytic domain...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Petros D. Grivas, Kathleen C. Day, Andreas Karatsinides, Alyssa Paul, Nazia Shakir, Iya Owainati, Monica Liebert, Lakshmi P. Kunju, Dafydd Thomas, Maha Hussain, Mark L. Day
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: BMC 2013-10-01
Loạt:Molecular Medicine
Những chủ đề:
Dacomitinib
Bladder Cancer Xenografts
Non-obese Diabetic/severe Combined Immunodeficiency (NOD/SCID)
Epidermal Growth Factor Receptor (EGFR)
Lapatinib
Truy cập trực tuyến:https://doi.org/10.2119/molmed.2013.00108

Internet

https://doi.org/10.2119/molmed.2013.00108

Những quyển sách tương tự